XML 36 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Deficit (Details Textual) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Jul. 01, 2019
Dec. 12, 2018
Nov. 30, 2018
Jul. 01, 2019
Feb. 28, 2019
Sep. 30, 2018
Sep. 30, 2019
2019 Private Placement [Member]              
Class of Stock [Line Items]              
Fair value of warrant issued             $ 1,593,559
Maximum offering of units under private placement             4,000,000
Maximum offering, units per share             $ 2.50
Risk free interest rate             2.40%
Expected stock price volatility             50.60%
Expected life of years             4 years 9 months 18 days
Expected dividend yield             0.00%
Cost of issuance             $ 1,150,359
Issuance cost commission, percentage             8.00%
Issuance cost commission amounting             $ 649,654
Exercise price, per share             $ 3.00
Common stock purchase price, per share             10.00%
Estimated value of warrants excercise price issued, term             5 years
Private placement exercise price             $ 2.75
Broker warrants to be issued shares 346,689            
Legal costs related to private placement issuance costs             $ 153,286
Warrants issued, value             $ 347,419
2019 Private Placement [Member] | Paulson [Member]              
Class of Stock [Line Items]              
Issuance cost commission, percentage             12.00%
Estimated value of warrants excercise price issued, term             5 years
Private placement transaction, description             HRA received a cash commission equal to 8% of the gross proceeds from the sale of the 2019 Units sold by HRA. In addition to the brokers' commission, the Company issued 17,760 warrant shares to HRA to purchase an amount of common stock equal to 8% of the total amount of common stock sold by HRA in the 2019 Private Placement at an exercise price of $3.00 per share with a term of 5 years upon the termination of the 2019 Private Placement. Lastly, in July 2019, the Company agreed to compensate HRA with additional 5-year warrants to purchase an amount of common stock equal to 135,512 shares at an exercise price of $2.00 per share for HRA's ultimate participation in the 2019 Private Placement.
Warrants shares issued             193,417
2019 Private Placement [Member] | Warrant [Member]              
Class of Stock [Line Items]              
Maximum shares of common stock issuable under private placement             4,000,000
Maximum potential gross proceeds from financing             $ 10,000,000
Private Placement [Member]              
Class of Stock [Line Items]              
Offering price, per share   $ 2.50          
Gross proceeds from private placement   $ 5,845,448          
Private placement transaction, description   (i) 1 share of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the "2019 Warrants"), to the New Purchasers.          
Shares issued under private placement   2,338,179          
2018 Private Placement [Member]              
Class of Stock [Line Items]              
Purchase agreement, description     (i) 1 share (each, a "Share") of common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the "2018 Warrants").        
Offering price, per share   $ 2.50          
Fair value of warrant issued           $ 288,106 $ 115,674
Risk free interest rate           2.80% 2.90%
Expected stock price volatility           49.80% 49.80%
Expected life of years           4 years 10 months 25 days 4 years 7 months 6 days
Expected dividend yield           0.00% 0.00%
Cost of issuance           $ 173,067 $ 18,320
Issuance cost commission, percentage             8.00%
Exercise price, per share             $ 3.00
Estimated value of warrants excercise price issued, term             5 years
Units sold under private placement           445,200 170,000
Gross proceeds from private placement   $ 1,538,000          
Broker warrants to be issued shares       36,096      
Private placement transaction, description         (i) to extend the Tail Period until June 30, 2019, (ii) to modify the HRA Fee so that HRA is entitled to receive a cash fee equal to 8% of the gross proceeds received by the Company from Prospects in all subsequent private placement transactions and (iii) to modify the HRA Warrants so that they are exercisable to purchase shares of Common Stock (or common stock equivalents) in an amount equal to 8% of the shares of Common Stock purchased by Prospects in subsequent private placements (collectively, the "HRA Amendments"). Upon issuance, the HRA Warrants will be immediately exercisable and expire five years from the closing of the related transaction.    
Shares issued under private placement   615,200          
Legal costs related to private placement issuance costs           $ 62,389 $ 7,340
Brokerage commission           $ 83,800 $ 6,440
Percentage of cash commission and broker warrants             8.00%
Payment for HRA fee, description         The Company amended its engagement letter with one of its placement agents in the 2018 Private Placement, HRA Capital ("HRA"), acting through its affiliate, Corinthian Partners, LLC, each of which are affiliates of one of the Company's greater than 5% stockholders. Pursuant to the original agreement (prior to the amendment), the Company agreed to pay HRA 10% of the gross proceeds (the "HRA Fee") received by the Company in subsequent private placement transactions from investors with whom HRA or Corinthian Partners, LLC had material contact with for purposes of the engagement letter (the "Prospects"), provided such compensation would only be paid in connection with private placement transactions that closed within 12 months of the expiration of the engagement letter (the "Tail Period"). The Company agreed to issue to HRA warrants to purchase shares of Common Stock (or common stock equivalents) in an amount equal to 10% of the shares purchased by Prospects during the Tail Period ("HRA Warrants").    
Brokerage warrants fair value       $ 31,418